Precision Medicine

AstraZeneca's COVID-19 vaccine 90% effective, results show

AstraZeneca COVID-19 coronavirus vaccine effectiveness 90% efficacy

AstraZeneca's vaccine has been developed at Oxford University. Image: Getty Images/Paul Ellis

Kate Holton
Chief Correspondent , Thomson Reuters
Josephine Mason
Share:
The Big Picture
Explore and monitor how Precision Medicine is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Precision Medicine

AstraZeneca COVID-19 coronavirus vaccine effectiveness 90% efficacy
AstraZeneca's vaccine hasn't shown any serious side effects in its most recent trial. Image: Reuters/Dado Ruvic
Have you read?
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Precision MedicineCOVID-19Global HealthVaccination
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

More on Precision Medicine
See all

Research reveals the links between viruses and Alzheimer's disease

Ruth Itzhaki

November 24, 2022

Accelerating Global Access to Gene Therapies: Case Studies from Low- and Middle-Income Countries

About Us

Events

Media

More from the Forum

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum